Improved Cav2.2 Channel Inhibitors through agem-Dimethylsulfone Bioisostere Replacement of a Labile Sulfonamide
- 13 September 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 4 (11) , 1064-1068
Abstract
We report the investigation of sulfonamide-derived Cav2.2 inhibitors to address drug-metabolism liabilities with this lead class of analgesics. Modification of the benzamide substituent provided improvements in both potency and selectivity. However, we discovered that formation of the persistent 3-(trifluoromethyl)benzenesulfonamide metabolite was an endemic problem in the sulfonamide series and that the replacement of the center aminopiperidine scaffold failed to prevent this metabolic pathway. This issue was eventually addressed by application of a bioisostere strategy. The new gem-dimethyl sulfone series retained Cav2.2 potency without the liability of the circulating sulfonamide metabolite.Keywords
This publication has 9 references indexed in Scilit:
- Aminopiperidine Sulfonamide Cav2.2 Channel Inhibitors for the Treatment of Chronic PainJournal of Medicinal Chemistry, 2012
- Mitigating Heterocycle Metabolism in Drug DiscoveryJournal of Medicinal Chemistry, 2012
- 4-Methyl-5-phenyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type IBioorganic & Medicinal Chemistry Letters, 2008
- A High-Throughput Assay for Evaluating State Dependence and Subtype Selectivity of Cav2 Calcium Channel InhibitorsASSAY and Drug Development Technologies, 2008
- CYP3A4 Induction by Xenobiotics: Biochemistry, Experimental Methods and Impact on Drug Discovery and DevelopmentCurrent Drug Metabolism, 2004
- Pre‐ and postsynaptic contributions of voltage‐dependent Ca2+ channels to nociceptive transmission in rat spinal lamina I neuronsEuropean Journal of Neuroscience, 2003
- Functional and pharmacological properties of canine ERG potassium channelsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2003
- Rational Use of in Vitro P-glycoprotein Assays in Drug DiscoveryThe Journal of Pharmacology and Experimental Therapeutics, 2001
- Evidence that adjuvant arthritis in the rat is associated with chronic painPain, 1987